Preclinical evaluation of 9-chloro-2-methylellipticinium acetate alone and in combination with conventional anticancer drugs for the treatment of human brain tumor xenografts.

Autor: Arguello, Francisco, Alexander, Mark A., Greene Jr., John F., Stinson, Sherman F., Jorden, Jean L., Smith, Erik M., Kalavar, Naina T., Alvord, W. Gregory, Klabansky, Richard L., Sausville, Edward A.

Publikováno v: Journal of Cancer Research & Clinical Oncology; Feb1998, Vol. 124 Issue 1, p19-26, 8p

Receptor glycosylation regulates Ly-49 binding to MHC class I.

Autor: Mason LH; Laboratory of Experimental Immunology, Division of Basic Sciences, National Cancer Institute-Clinical Cancer Research, National Institutes of Health, Frederick, MD 21702-1201, USA. MasonL@mail.ncifcrf.gov, Willette-Brown J, Anderson SK, Alvord WG, Klabansky RL, Young HA, Ortaldo JR

Publikováno v: Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2003 Oct 15; Vol. 171 (8), pp. 4235-42.